The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has allowed cheaper, off-brand versions to flourish. Source link : https://www.washingtonpost.com/business/2024/08/30/mounjaro-zepbound-eli-lilly-weight-loss-drugs/ Author : Daniel Gilbert Publish date : 2024-08-30 17:41:52 Copyright for syndicated content belongs to the linked Source.